GHRP-2
Growth Hormone Releasing Peptide-2
GHRP-2 (Growth Hormone Releasing Peptide-2), also known as pralmorelin, is a synthetic hexapeptide that acts as a potent agonist at the ghrelin/growth hormone secretagogue receptor (GHS-R). It triggers pulsatile growth hormone release from the pituitary gland, mimicking the body's natural GH secretion patterns. GHRP-2 was developed as a diagnostic agent and is clinically approved in Japan for assessing growth hormone deficiency. Unlike direct GH administration, GHRP-2 works through the body's natural pathways, making it a preferred option for those seeking to enhance their natural growth hormone production safely and effectively.
Complete Dosing Guide
What to Monitor
Growth Hormone Markers:
- IGF-1 levels (check baseline and every 4 weeks)
- GH levels (if clinically indicated)
- Monitor for adequate response
Metabolic Parameters:
- Fasting glucose and HbA1c
- Insulin sensitivity
- Lipid profile
- Body composition (DEXA scan if available)
Other Hormones:
- Cortisol levels (if using high doses)
- Prolactin (if experiencing side effects)
- Thyroid function (TSH, T3, T4)
Clinical Monitoring:
- Blood pressure
- Signs of edema or fluid retention
- Joint pain or stiffness
- Sleep quality and recovery
Medical Disclaimer
Clinical data presented is from peer-reviewed studies. Individual results may vary. Consult healthcare professionals before starting treatment. This information is for educational purposes only.